Ganaxolone IV for Treatment in Epilepsy

PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Edit

Updated: 08/27/2019

Pipeline Type

New Drugs in Development

Phase Of Development

Phase 2

Sponsors and Collaborators

Marinus Pharmaceuticals, Epilepsy Foundation (EF)

Mechanism of Action

GABA

Mechanism Description

synthetic analog of endogenous allopregnanolone which modulats GABAa Receptors

Populations Tested In

Status Epilepticus

Other Resources

Special FDA Designation

Nonprofit or Government Support

Nonprofit

Nonprofit or Government Support Description

Epilepsy Foundation - 2005 investment

Previous Presentations

Presented at meetings (latest date) (Pipeline, AEDD; AES, Eilat, etc)
N/A

Location of Clinical Trials

N/A

Sign Up for Emails

Stay up to date with the latest epilepsy news, stories from the community, and more.